IDH突变胶质瘤的[18F]FET PET与MRI特征:基于WHO 2021分类的回顾性分析
该回顾性研究纳入147例初诊IDH突变胶质瘤患者,分析[18F]FET PET参数与MRI表现及神经病理结果的关系。结果显示,PET摄取强度与WHO分级正相关,但各分级间重叠明显,且与增强MRI提供互补信息。
要点
- 少突胶质细胞瘤[18F]FET PET阳性率91.2%,星形细胞瘤44.3%,前者摄取强度更高。
- PET与增强MRI空间重叠低(中位Dice 0.26),与FLAIR重叠较高(中位Dice 0.55)。
- WHO 4级星形细胞瘤TTPmin集中于早期12.5分钟组,2–3级峰值较晚(17.5–35分钟)。
原文
PURPOSE: Amino acid positron emission tomography (PET) is increasingly utilized in the clinical workup of patients with glioma. To better understand the PET characteristics of IDH-mutant glioma according to the 2021 WHO classification of CNS tumours, this retrospective study explored the association between amino acid PET and magnetic resonance imaging (MRI) characteristics in patients with newly diagnosed IDH-mutant glioma. METHODS: Patients with histologically verified IDH-mutant glioma who underwent [18F]FET PET/CT scans without prior treatment were included. PET parameters (PET-positivity according to PET RANO 1.0 criteria, maximal and mean tumour-to-background ratio (TBRmax, TBRmean), PET volume and uptake kinetics including minimal time-to-peak (TTPmin)) were assessed and compared with neuropathological findings and contrast-enhanced MRI including Dice similarity coefficients for spatial overlap between PET and MR signals. RESULTS: A total of 147 patients were included (79 astrocytomas, 68 oligodendrogliomas). Contrast enhancement was present in 44/147 tumours (29.9%), most frequently in astrocytoma WHO grade 4 (8/9, 88.9%). [¹⁸F]FET PET was positive in 62/68 oligodendrogliomas (91.2%) and 35/79 astrocytomas (44.3%), with significantly higher uptake intensities in oligodendrogliomas (median TBRmax 2.43 vs. 1.55; p < 0.001) and increasing values with WHO grade. PET–CE spatial overlap was generally low (median Dice 0.26 (range: 0.01–0.90)), whereas PET–FLAIR overlap was higher (median Dice 0.55 (range: 0.05–0.99)) and showed significant differences between histologies and grades. Dynamic [¹⁸F]FET PET data were available in 91/147 tumours (61.9%) and demonstrated predominantly increasing kinetics (61.5%). In the TTPmin analysis, WHO grade 4 astrocytomas clustered in the early 12.5-min group, whereas WHO grade 2–3 gliomas showed later peaks (17.5–35 min). CONCLUSION: [18F]FET PET uptake intensity correlates positively with the CNS WHO grade in IDH-mutant gliomas, but with marked overlap between tumour grades, and provides complementary information to contrast-enhanced MRI. [18F]FET PET may therefore add another layer of information on tumour characteristics and should be further investigated as a complementary biomarker.
引用
- Barci E, Mair MJ, Reis J, et al. Characteristics of [18F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification - a retrospective analysis. Eur J Nucl Med Mol Imaging. 2026. PMID: 41571842. doi:10.1007/s00259-026-07760-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。